소장 점막하층(SIS) 시장 규모, 점유율, 성장 분석 : 제품 유형별, 원료별, 용도별, 최종사용자별, 지역별 - 산업 예측(2026-2033년)

Global Small Intestinal Submucosa (Sis) Market size was valued at USD 748.0 Million in 2024 and is poised to grow from USD 813.08 Million in 2025 to USD 1584.78 Million by 2033, growing at a CAGR of 8.7% during the forecast period (2026-2033).

The global Small Intestinal Submucosa (SIS) market focuses on a biologically derived scaffold that plays a vital role in regenerative medicine, wound care, and veterinary applications. Its unique ability to encourage cellular infiltration and vascularization while minimizing immunogenic responses makes SIS a favored option over synthetic alternatives. The growing demand for minimally invasive regenerative therapies, particularly among aging populations, is a key driver of SIS market expansion. Surgeons increasingly prefer SIS-based products for procedures such as pelvic organ prolapse repair and rotator-cuff surgery, leading to greater healthcare investments in biologics. Additionally, the veterinary sector in Europe and Asia is adopting SIS for tendon repairs in racehorses. Innovations in AI-driven tissue engineering are enhancing scaffold design and biocompatibility testing, further propelling market growth and investment.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Small Intestinal Submucosa (Sis) market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Small Intestinal Submucosa (Sis) Market Segments Analysis

Global small intestinal submucosa (sis) market is segmented by product type, source, application, end user and region. Based on product type, the market is segmented into Sheets, Meshes, Particulate & Powder and Injectable Forms. Based on source, the market is segmented into Porcine SIS, Bovine SIS and Other Animal Sources. Based on application, the market is segmented into Wound Care, Hernia Repair, Cardiovascular Repair, Orthopedic & Sports Medicine, Urology & Gynecology and Other Soft Tissue Repair. Based on end user, the market is segmented into Hospitals, Ambulatory Surgical Centers, Specialty Clinics and Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Small Intestinal Submucosa (Sis) Market

The rising incidence of chronic wounds and organ defects is prompting healthcare providers to pursue biologically compatible scaffolds that promote natural tissue regeneration. Small intestinal submucosa (SIS) presents a native extracellular matrix that effectively supports cellular adhesion, proliferation, and remodeling, which aligns with clinical goals aimed at enhancing patient outcomes. With a focus on minimally invasive techniques, the inherent biocompatibility and structural integrity of SIS improve procedural efficiency, thereby facilitating its broader use in various therapeutic fields. This trend not only supports ongoing market growth but also encourages collaboration among interdisciplinary research teams to innovate and refine treatment approaches.

Restraints in the Global Small Intestinal Submucosa (Sis) Market

The complex extraction and purification processes necessary to preserve the native extracellular matrix of Small Intestinal Submucosa (SIS) lead to high manufacturing costs. These expenses stem from the need for specialized facilities, rigorous quality control measures, and labor-intensive handling, which together increase the unit price of SIS products. As a result, healthcare providers, especially in budget-limited hospitals and clinics, may lean towards more affordable synthetic alternatives, thereby restricting the growth and acceptance of SIS-based solutions. This financial pressure particularly impacts emerging markets, where constrained budgets for advanced wound care lead procurement committees to favor cost-effectiveness over superior quality.

Market Trends of the Global Small Intestinal Submucosa (Sis) Market

The Global Small Intestinal Submucosa (SIS) market is witnessing a significant upward trend as clinicians integrate SIS into multi-modal regenerative treatment protocols. This combination of SIS with growth factors, stem cell therapies, and advanced wound-care strategies is broadening its application beyond traditional abdominal surgeries to encompass complex trauma, orthopedic repairs, and chronic ulcer management. Collaborative research networks are enhancing knowledge transfer, encouraging innovations, while hospital formularies increasingly prioritize versatile SIS products that minimize operative times. Consequently, this trend fosters greater institutional confidence and acceptance, resulting in expanding market penetration across various clinical environments and significantly enhancing the overall demand for SIS solutions.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Small Intestinal Submucosa (SIS) Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Sheets
• Meshes
• Particulate & Powder
• Injectable Forms

Global Small Intestinal Submucosa (SIS) Market Size by Source & CAGR (2026-2033)

• Market Overview
• Porcine SIS
• Bovine SIS
• Other Animal Sources

Global Small Intestinal Submucosa (SIS) Market Size by Application & CAGR (2026-2033)

• Market Overview
• Wound Care
• Hernia Repair
• Cardiovascular Repair
• Orthopedic & Sports Medicine
• Urology & Gynecology
• Other Soft Tissue Repair

Global Small Intestinal Submucosa (SIS) Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Research Institutes

Global Small Intestinal Submucosa (SIS) Market Size & CAGR (2026-2033)

• North America (Product Type, Source, Application, End User)
  • US
  • Canada
• Europe (Product Type, Source, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Source, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Source, Application, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Source, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Cook Biotech Incorporated
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integra LifeSciences Holdings Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smith & Nephew plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MiMedx Group, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Organogenesis Holdings Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aroa Biosurgery Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Convatec Group plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter International Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Coloplast A/S
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Essity AB
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Molnlycke Health Care AB
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 3M Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Paul Hartmann AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DeRoyal Industries, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Anika Therapeutics, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioventus LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zimmer Biomet Holdings, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations